Krystal Biotech
KRYS
KRYS
365 hedge funds and large institutions have $7.32B invested in Krystal Biotech in 2026 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 136 increasing their positions, 103 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
10% more funds holding
Funds holding: 333 → 365 (+32)
4% more capital invested
Capital invested by funds: $7.02B → $7.32B (+$305M)
1.13% less ownership
Funds ownership: 98.16% → 97.03% (-1.1%)
Holders
365
Holding in Top 10
10
Calls
$81M
Puts
$31.8M
Top Buyers
| 1 | +$56.4M | |
| 2 | +$50.9M | |
| 3 | +$28M | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$21.2M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$19M |
Top Sellers
| 1 | -$102M | |
| 2 | -$30.7M | |
| 3 | -$20.9M | |
| 4 |
Corient Private Wealth
Miami,
Florida
|
-$19.5M |
| 5 |
Barclays
London,
United Kingdom
|
-$14.7M |
